Hub gene identification and immune infiltration analysis in hepatocellular carcinoma: Computational approach
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified novel immune biomarkers for hepatocellular carcinoma (liver cancer) prognosis. These hub genes can guide future immunotherapy strategies to improve patient survival.
Area Of Science
- Oncology
- Immunology
- Bioinformatics
Background
- Hepatocellular carcinoma (HCC) necessitates novel immune biomarkers for improved prognosis and patient survival.
- Identifying predictive biomarkers is crucial for advancing HCC immunotherapy.
Purpose Of The Study
- To computationally identify hub genes in hepatocellular carcinoma.
- To explore the role of these hub genes in predicting cancer prognosis and guiding immunotherapy.
Main Methods
- Utilized three Gene Expression Omnibus (GEO) datasets (GSE25097, GSE76427, GSE84402).
- Employed the Gene Expression Analysis Platform (GEAP) for differential gene expression (DEG) analysis.
- Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses.
- Identified gene associations using Cytoscape software.
- Screened hub genes via immune cell infiltration and correlation analyses.
Main Results
- Identified ten hub genes: PTTG1, NCAPG, RACGAP1, PBK, ASPM, AURKA, CDCA5, KIF20A, MELK, and PRC1.
- These genes demonstrated a correlation with immune targets relevant to hepatocellular carcinoma.
Conclusions
- The identified hub genes serve as potential biomarkers for hepatocellular carcinoma prognosis.
- These biomarkers can facilitate the development of targeted immunotherapies for HCC patients.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.